Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The independent source for health policy research, polling, and news.
401 - 420 of 524 Results
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Lawyers seeking to block the Trump administration’s decision to alter rules for the Title X family planning program say their efforts will not be stymied by the Supreme Court’s approval of similar rules 28 years ago. They point to new protections enacted in the Affordable Care Act and language in funding bills that shifts the legal calculus.
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The president’s promise to eliminate HIV transmission within 10 years is a goal long sought by advocates, but it won’t be an easy undertaking.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Democratic governors and mayors are unveiling new ideas to control costs and expand coverage. The federal government shutdown has spared most health agencies, but not all. And learn the latest on that lawsuit out of Texas, which is threatening the Affordable Care Act once again. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN’s Jordan Rau about the latest “Bill of the Month.”
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Medicare and Medicaid are fine, but the food safety component of the Food and Drug Administration and bio-threat surveillance done by the Department of Homeland Security are among the public health functions feeling the pinch.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
There could be a long legal struggle ahead over the decision by a judge in Texas to invalidate the federal health law. But if his decision stands, it would have long-lasting effects on health care from insurance coverage to Medicare payments to privacy protections.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Sign-ups for insurance under the Affordable Care Act are still well behind last year’s mark with just a week until the end of open enrollment in most states. The Supreme Court declines a case that could have allowed states to defund Planned Parenthood. And the Trump administration gets hundreds of thousands of comments about its proposed changes to immigration rules that could penalize people who use government-funded health care and other social service programs. Alice Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week.
Diabetics dying because they can’t afford insulin. Organ transplant patients undergoing “wallet biopsies” to get on waiting lists. Are out-of-pocket costs going to dominate the health discussion in the next election? Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss this as well as new Trump administration rules giving states the ability to make major changes to the Affordable Care Act. Also, lame-duck lawmakers in Wisconsin and Michigan try to cement health changes before Democrats take over.
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats’ takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.
© 2026 KFF